Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging

scientific article published on May 2009

Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAD.0B013E328329C76B
P932PMC publication ID2786203
P698PubMed publication ID19318907

P50authorValentín Fuster CarullaQ977751
Venkatesh ManiQ47840811
P2093author name stringJoan W Berman
Zahi A Fayad
Robert S Klein
Andrea A Howard
Alison D Schecter
Yungtai Lo
Ellie E Schoenbaum
Michelle Floris-Moore
Karen B Weinshelbaum
P2860cites workReport of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusQ29616284
Endothelial dysfunction, hemodynamic forces, and atherogenesisQ33949677
Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cellsQ34229735
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposureQ34374679
Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndromeQ35492436
Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaqueQ35739811
MRI of atherosclerosis in clinical trialsQ36598512
Androgen levels in older men who have or who are at risk of acquiring HIV infectionQ36718062
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurementsQ38266446
Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart StudyQ40640856
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.Q41082129
Formation of the arterial media during vascular development.Q41086435
HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosisQ42958246
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartQ43491095
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunctionQ43678570
The reliability of high resolution MRI in the measurement of early stage carotid wall thickeningQ43778773
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infectionQ44801351
Human vascular smooth muscle cells possess functional CCR5.Q44837410
Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunctionQ45486626
Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients.Q45743888
Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infectionQ45759106
Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.Q46754875
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.Q51472489
Menopause symptoms in HIV-infected and drug-using women.Q51930340
Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-alpha: a basis for local variations in vascular sensitivity to inflammation.Q54766354
Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionQ57181081
Surgical Experience with Carotid Stenosis in Young HIV-1 Positive Patients Under Antiretroviral Therapy: An Emerging Problem?Q58812800
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1Q59540685
Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 AlleleQ59540708
Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individualsQ80134146
Rapid extended coverage simultaneous multisection black-blood vessel wall MR imagingQ80248650
P4510describes a project that usesmagnetic resonance imagingQ161238
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectHIVQ15787
viral loadQ2528140
atherosclerosisQ12252367
HIV viral loadQ106686843
P304page(s)941-949
P577publication date2009-05-01
P1433published inAIDSQ4651863
P1476titleAssociation of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging
P478volume23

Reverse relations

cites work (P2860)
Q24622468A genome-wide association study of carotid atherosclerosis in HIV-infected men
Q36249027Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review
Q36662075Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance
Q37955129CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis
Q45325496Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency
Q92390696Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Q35473503Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection
Q92360248Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals
Q58798012From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
Q39185675HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease
Q36285922HIV infection and stroke: current perspectives and future directions
Q37984849Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond
Q64077947Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study
Q50146220Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.
Q35921028Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy
Q36966437Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy
Q37248840Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy
Q37543248Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.
Q36104762Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment
Q92290439Subclinical Atherosclerosis Imaging in People Living with HIV
Q42175449The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients

Search more.